Microbiome and the Gut-Lung Axis in Emerging Viral Respiratory Infections

View Full Paper

Ask AI

Bookmark

A disrupted gut microbiota may weaken the immune response, increasing susceptibility to severe respiratory illnesses.
Research indicates that gut microbial profiles can impact the prognosis of viral infections, such as COVID-19 and influenza.
Microbial metabolite therapies, including probiotics and fecal transplants, are being explored to improve lung infection outcomes.
Understanding the gut-lung axis may lead to personalized treatment options for high-risk patients, enhancing epidemic preparedness.

Authors

Discussion

No takes yet. Share an insight, caveat, or question.

Research shows gut-lung axis influences immune responses in respiratory infections, suggesting targeted therapies may enhance patient outcomes.

Jimil Shah (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Research shows gut-lung axis influences immune responses in respiratory infections, suggesting targeted therapies may enhance patient outcomes.